Upload
PPT-Figure 3 Figure 3. Use of depletion of human serum with DENV antigen to distinguish Zika

PPT-Figure 3 Figure 3. Use of depletion of human serum with DENV antigen to distinguish Zika

Author : roberto | Published Date : 2024-10-04

Collins MH McGowan E Jadi R Young E Lopez CA Baric RS et al Lack of Durable CrossNeutralizing Antibodies Against Zika Virus from Dengue Virus Infection Emerg Infect

denv serum zika virus serum denv virus zika dengue measured depletion elisa binding depleted antibodies cross

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 3 Figure 3. Use of depletion of h..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 3 Figure 3. Use of depletion of human serum with DENV antigen to distinguish Zika: Transcript

Collins MH McGowan E Jadi R Young E Lopez CA Baric RS et al Lack of Durable CrossNeutralizing Antibodies Against Zika Virus from Dengue Virus Infection Emerg Infect Dis 2017235773781 httpsdoiorg103201eid2305161630. . Information for Clinicians. Updated . August 5, . 2016. This training provides clinicians with information . about. Zika virus epidemiology. Diagnoses and testing. Case reporting. Zika and pregnancy. Test appropriate specimen by Zika . RNA. PCR/NAT. Dengue. Chikungunya. Specimen positive for RNA patient . POSITIVE. for . dengue. virus. Specimen negative for dengue virus RNA. Specimen positive for chikungunya virus – . Bureau of Workers’ Compensation . PA Training for Health & Safety (PATHS). Zika Virus Basics. Common Name: Asian tiger . mosquito. Scientific name: Aedes albopictus (Skuse. Division of Public Health. Background. Mosquito-borne emerging . arbovirus. . Closely related to dengue, yellow fever, Japanese encephalitis and West Nile viruses. First identified in Uganda in 1947. Griffin I, Martin SW, Fischer M, Chambers TV, Kosoy OL, Goldberg C, et al. Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA. Emerg Infect Dis. 2019;25(12):2264-2265. https://doi.org/10.3201/eid2512.191022. Griffin I, Martin SW, Fischer M, Chambers TV, Kosoy O, Falise A, et al. Zika Virus IgM Detection and Neutralizing Antibody Profiles 12–19 Months after Illness Onset. Emerg Infect Dis. 2019;25(2):299-303. https://doi.org/10.3201/eid2502.181286. Reperant LA, van Amerongen G, van de Bildt MW, Rimmelzwaan GF, Dobson AP, Osterhaus A, et al. Highly Pathogenic Avian Influenza Virus (H5N1) Infection in Red Foxes Fed Infected Bird Carcasses. Emerg Infect Dis. 2008;14(12):1835-1841. https://doi.org/10.3201/eid1412.080470. Wawina-Bokalanga T, Vanmechelen B, Lhermitte V, Martí-Carreras J, Vergote V, Koundouno F, et al. Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes. Emerg Infect Dis. 2021;27(1):76-84. https://doi.org/10.3201/eid2701.202177. Goncé A, Martínez MJ, Marbán-Castro E, Saco A, Soler A, Alvarez-Mora M, et al. Spontaneous Abortion Associated with Zika Virus Infection and Persistent Viremia. Emerg Infect Dis. 2018;24(5):933-935. https://doi.org/10.3201/eid2405.171479. Guo L, Zhang X, Ren L, Yu X, Chen L, Zhou H, et al. Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013. Emerg Infect Dis. 2014;20(2):192-200. https://doi.org/10.3201/eid2002.131094. Bozza FA, Moreira-Soto A, Rockstroh A, Fischer C, Nascimento AD, Calheiros AS, et al. Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil. Emerg Infect Dis. 2019;25(2):311-315. https://doi.org/10.3201/eid2502.180166. Honkavuori KS, Shivaprasad HL, Briese T, Street C, Hirschberg DL, Hutchison SK, et al. Novel Picornavirus in Turkey Poults with Hepatitis, California, USA. Emerg Infect Dis. 2011;17(3):480-487. https://doi.org/10.3201/eid1703.101410. Keawcharoen J, van Riel D, van Amerongen G, Bestebroer TM, Beyer WE, van Lavieren R, et al. Wild Ducks as Long-Distance Vectors of Highly Pathogenic Avian Influenza Virus (H5N1). Emerg Infect Dis. 2008;14(4):600-607. https://doi.org/10.3201/eid1404.071016. Buehring G, Shen H, Jensen HM, Choi K, Sun D, Nuovo G. Bovine Leukemia Virus DNA in Human Breast Tissue. Emerg Infect Dis. 2014;20(5):772-782. https://doi.org/10.3201/eid2005.131298.

Download Document

Here is the link to download the presentation.
"Figure 3 Figure 3. Use of depletion of human serum with DENV antigen to distinguish Zika"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Serological Testing Serum specimens should be tested by an IgM assay**

Serological Testing Serum specimens should be tested by an IgM assay**
Zika Virus Basics 1 PPT-146-01

Zika Virus Basics 1 PPT-146-01
Zika Virus North Carolina Department of Health and Human Services,

Zika Virus North Carolina Department of Health and Human Services,
Figure Figure. Estimated proportion of persons with detectable Zika virus IgM up to 25

Figure Figure. Estimated proportion of persons with detectable Zika virus IgM up to 25
Figure Figure. Zika virus IgM results for 62 participants in Miami–Dade County, Florida,

Figure Figure. Zika virus IgM results for 62 participants in Miami–Dade County, Florida,
Figure 2 Figure 2. Lesions and associated expression of influenza virus antigen

Figure 2 Figure 2. Lesions and associated expression of influenza virus antigen
Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,

Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,
Figure Figure. Clinical timeline for a 22-year-old pregnant woman who had suspected Zika

Figure Figure. Clinical timeline for a 22-year-old pregnant woman who had suspected Zika
Figure 1 Figure 1. Serum antibodies (Abs) in patients infected with influenza A(H7N9)

Figure 1 Figure 1. Serum antibodies (Abs) in patients infected with influenza A(H7N9)
Figure 2 Figure 2. Zika virus and CHIKV antibody dynamics among samples from patients

Figure 2 Figure 2. Zika virus and CHIKV antibody dynamics among samples from patients
Figure 2 Figure 2. Relationships between turkey hepatitis virus (THV) and other

Figure 2 Figure 2. Relationships between turkey hepatitis virus (THV) and other
Appendix Figure 4 Appendix Figure 4. Highly pathogenic avian influenza virus

Appendix Figure 4 Appendix Figure 4. Highly pathogenic avian influenza virus
Figure 4 Figure 4. Test results showing lack of cross-reactivity of bovine leukemia virus

Figure 4 Figure 4. Test results showing lack of cross-reactivity of bovine leukemia virus